Malaria Birth Cohort (MBC) in Agogo, Ghana
NCT04050566 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800
Last updated 2021-09-01
Summary
Malaria is a major health threat worldwide with an estimated 229 million cases and 409,000 deaths in 2019 (WHO, World Malaria Report 2019). Vulnerable are young children and pregnant women. The study aims to investigate immunity development against malaria with regard to parasite, human, and socioeconomic factors and possible correlations with pathology or protection in a prospective birth cohort.
Conditions
Sponsors & Collaborators
-
Kwame Nkrumah University of Science and Technology
collaborator OTHER -
Kumasi Centre for Collaborative Research (KCCR)
collaborator OTHER -
Heidelberg University
collaborator OTHER -
KEMRI-Wellcome Trust Collaborative Research Program
collaborator OTHER -
Agogo Presbyterian Hospital
collaborator UNKNOWN -
Bernhard Nocht Institute for Tropical Medicine
lead OTHER_GOV
Principal Investigators
-
Jürgen May, Prof · Bernhard Nocht Institute for Tropical Medicine
-
John H Amuasi, Dr · Kwame Nkrumah University of Science & Technology (KNUST)
-
Eva Mertens, PhD · Bernhard Nocht Institute for Tropical Medicine
-
Nicole Struck, PhD · Bernhard Nocht Institute for Tropical Medicine
-
Oumou Maiga-Ascofaré, PhD · Kumasi Centre for Collaborative Research
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-08
- Primary Completion
- 2025-04-30
- Completion
- 2025-04-30
Countries
- Ghana
Study Locations
More Related Trials
-
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
NCT01168271 ·Status: RECRUITING
-
Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment
NCT00258024 ·Status: COMPLETED ·Phase: NA
-
A Trial of Improved Financial Access to Healthcare in Ghana
NCT00146692 ·Status: COMPLETED ·Phase: PHASE4
-
Malarial Immunity in Pregnant Cameroonian Women
NCT00593398 ·Status: COMPLETED
-
Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy
NCT00432367 ·Status: COMPLETED ·Phase: PHASE3
-
MiMBa Pregnancy Registry
NCT04825782 ·Status: UNKNOWN
-
Congenital and Neonatal Malaria in Mali
NCT00384267 ·Status: COMPLETED
-
Age of Exposure and Immunity to Malaria in Infants
NCT00231452 ·Status: COMPLETED ·Phase: NA
-
Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali
NCT03035305 ·Status: COMPLETED ·Phase: NA
-
Africa Ready Malaria Screening
NCT06153862 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Malaria on Pregnant Women in Ouelessebougou, Mali
NCT02974608 ·Status: COMPLETED
-
Community-based Screening and Treatment of Malaria in Pregnancy: a Cluster-randomized Trial
NCT01941264 ·Status: COMPLETED ·Phase: NA
-
Plasmodium Resistance in A. Gambiae
NCT00466557 ·Status: COMPLETED
-
Human Immunity to MSP-1 in Western Kenya
NCT00138372 ·Status: COMPLETED
-
Non-malarial Febrile Illness in Children in Areas of Perennial Malaria Transmission
NCT01043744 ·Status: COMPLETED ·Phase: NA
-
Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children
NCT06524336 ·Status: ACTIVE_NOT_RECRUITING
-
Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire
NCT05856357 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin
NCT05650502 ·Status: COMPLETED
-
Intermittent Preventive Treatment With Antimalarials in Kenyan Infants
NCT00111163 ·Status: COMPLETED ·Phase: NA
-
Malaria Vaccine in Children in Mali
NCT00341250 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, Mali
NCT02659566 ·Status: COMPLETED
-
Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge
NCT07082205 ·Status: RECRUITING ·Phase: PHASE3
-
A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
NCT02374450 ·Status: COMPLETED
-
Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso
NCT00261222 ·Status: COMPLETED ·Phase: PHASE2
-
Child Follow-up Until 2 Years
NCT02800109 ·Status: COMPLETED